Published online Jun 28, 2021. doi: 10.37126/aige.v2.i3.89
Peer-review started: June 2, 2021
First decision: June 18, 2021
Revised: June 20, 2021
Accepted: June 28, 2021
Article in press: June 28, 2021
Published online: June 28, 2021
Processing time: 33 Days and 18.6 Hours
The application of artificial intelligence (AI) using deep learning and machine learning approaches in modern medicine is rapidly expanding. Within the field of Gastroenterology, AI is being evaluated across a breadth of clinical and diagnostic applications including identification of pathology, differentiation of disease processes, and even automated procedure report generation. Many pancreatic pathologies can have overlapping features creating a diagnostic dilemma that provides a window for AI-assisted improvement in current evaluation and diagnosis, particularly using endoscopic ultrasound. This topic highlight will review the basics of AI, history of AI in gastrointestinal endoscopy, and prospects for AI in the evaluation of autoimmune pancreatitis, pancreatic ductal adenocarcinoma, chronic pancreatitis and intraductal papillary mucinous neoplasm.
Core Tip: Artificial intelligence is an emerging diagnostic tool that may further aid clinicians in the current evaluation of diseases of the pancreas.
